相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Racial differences in outcomes of triple-negative breast cancer
Jose M. Pacheco et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Relapsed Classic E-Cadherin (CDH1)-Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations
Jeffrey S. Ross et al.
CLINICAL CANCER RESEARCH (2013)
Therapeutic targets in triple negative breast cancer
Sandra A. O'Toole et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Emerging targeted agents in metastatic breast cancer
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
Aleix Prat et al.
ONCOLOGIST (2013)
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
Ron Bose et al.
CANCER DISCOVERY (2013)
The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
Impact of Breast Cancer Subtypes and Treatment on Survival: An Analysis Spanning Two Decades
Reina Haque et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Mutual exclusivity analysis identifies oncogenic network modules
Giovanni Ciriello et al.
GENOME RESEARCH (2012)
MuSiC: Identifying mutational significance in cancer genomes
Nathan D. Dees et al.
GENOME RESEARCH (2012)
Tumor Genetic Testing for Patient Selection in Phase I Clinical Trials: The Case of PI3K Inhibitors
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells
S. Cutrupi et al.
ONCOGENE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
Altaf A. Dar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients
Hege G. Russnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome
Andrew R. Green et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1
Aihua Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance
George W. Small et al.
CANCER RESEARCH (2007)
High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers
Naoshi Nishida et al.
CANCER BIOLOGY & THERAPY (2007)
Are clusters found in one dataset present in another dataset?
Amy V. Kapp et al.
BIOSTATISTICS (2007)
Novel patterns of genome rearrangement and their association with survival in breast cancer
James Hicks et al.
GENOME RESEARCH (2006)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Koei Chin et al.
CANCER CELL (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-α and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT
EK Keeton et al.
MOLECULAR ENDOCRINOLOGY (2005)
Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators
AH Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Circular binary segmentation for the analysis of array-based DNA copy number data
AB Olshen et al.
BIOSTATISTICS (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
